These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 2826609

  • 1. Severe, progressive herpetic whitlow caused by an acyclovir-resistant virus in a patient with AIDS.
    Norris SA, Kessler HA, Fife KH.
    J Infect Dis; 1988 Jan; 157(1):209-10. PubMed ID: 2826609
    [No Abstract] [Full Text] [Related]

  • 2. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.
    Erlich KS, Mills J, Chatis P, Mertz GJ, Busch DF, Follansbee SE, Grant RM, Crumpacker CS.
    N Engl J Med; 1989 Feb 02; 320(5):293-6. PubMed ID: 2536136
    [No Abstract] [Full Text] [Related]

  • 3. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    Chatis PA, Miller CH, Schrager LE, Crumpacker CS.
    N Engl J Med; 1989 Feb 02; 320(5):297-300. PubMed ID: 2536137
    [No Abstract] [Full Text] [Related]

  • 4. [Acyclovir-resistant herpes simplex virus infections in immunocompromised patients].
    Jansen CL, Maris-Tegeler WG, Wertheim-van Dillen PM, Frissen PH, Weiland HT, van der Noordaa J.
    Ned Tijdschr Geneeskd; 1992 Feb 08; 136(6):280-4. PubMed ID: 1311058
    [Abstract] [Full Text] [Related]

  • 5. Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome.
    Birch CJ, Tachedjian G, Doherty RR, Hayes K, Gust ID.
    J Infect Dis; 1990 Sep 08; 162(3):731-4. PubMed ID: 2167340
    [Abstract] [Full Text] [Related]

  • 6. Successful treatment of progressive acyclovir-resistant herpes simplex virus using intravenous foscarnet in a patient with the acquired immunodeficiency syndrome.
    Sall RK, Kauffman CL, Levy CS.
    Arch Dermatol; 1989 Nov 08; 125(11):1548-50. PubMed ID: 2554819
    [Abstract] [Full Text] [Related]

  • 7. Acyclovir resistant genital herpes virus infection in a patient with AIDS.
    Marrero M, Alvarez M, Millan JC, Mas Lago P, Soler M, Diaz M.
    Acta Virol; 1991 Jan 08; 35(1):86-9. PubMed ID: 1683121
    [Abstract] [Full Text] [Related]

  • 8. Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS.
    Gateley A, Gander RM, Johnson PC, Kit S, Otsuka H, Kohl S.
    J Infect Dis; 1990 Apr 08; 161(4):711-5. PubMed ID: 2156946
    [Abstract] [Full Text] [Related]

  • 9. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
    Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J, Kessler HA, Landry B, Mills J.
    N Engl J Med; 1991 Aug 22; 325(8):551-5. PubMed ID: 1649971
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/temperature-sensitive virus.
    Shimada Y, Suzuki M, Shirasaki F, Saito E, Sogo K, Hasegawa M, Takehara K, Phromjai J, Chuhjo T, Shiraki K.
    J Med Virol; 2007 Nov 22; 79(11):1731-40. PubMed ID: 17854045
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Herpetic whitlow.
    Giacobetti R.
    Int J Dermatol; 1979 Nov 22; 18(1):55-8. PubMed ID: 216646
    [Abstract] [Full Text] [Related]

  • 14. Clinical resistance to acyclovir of herpes simplex virus infections in immunocompromised patients.
    Christophers J, Sutton RN, Noble RV, Anderson H.
    J Antimicrob Chemother; 1986 Oct 22; 18 Suppl B():121-5. PubMed ID: 3025152
    [Abstract] [Full Text] [Related]

  • 15. [Resistance of herpes simplex virus to acyclovir: laboratory and clinical aspects].
    Briazzhikova TS, Iurlova TI, Chizhov NP.
    Antibiot Khimioter; 1995 Oct 22; 40(11-12):29-33. PubMed ID: 8830636
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
    Otegui M, Rabella N, Labeaga R, Herrero M, Margall N, Muñoz JM, Prats G.
    Rev Esp Quimioter; 2001 Dec 22; 14(4):351-7. PubMed ID: 11856981
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections.
    Birch CJ, Tyssen DP, Tachedjian G, Doherty R, Hayes K, Mijch A, Lucas CR.
    J Infect Dis; 1992 Jul 22; 166(1):108-12. PubMed ID: 1318909
    [Abstract] [Full Text] [Related]

  • 20. Herpes simplex virus type 2 latency in the footpad of mice: effect of acycloguanosine on the recovery of virus.
    Al-Saadi SA, Gross P, Wildy P.
    J Gen Virol; 1988 Feb 22; 69 ( Pt 2)():433-8. PubMed ID: 2828517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.